Literature DB >> 3082547

Mitogenic stimulation of malignant B cells Waldenstrøm's macroglobulinaemia: secretion of monoclonal IgM by in vitro-induced plasmablasts.

A C Bloem, M A Chand, B van Camp, E J Bast, R E Ballieux.   

Abstract

The monoclonal B cells present in the blood of three patients with Waldenstrøm's macroglobulinaemia were analysed according to phenotype and function. As a marker for the monoclonal nature of the detected immunoglobulin (Ig) molecules, the kappa/lambda-ratio (two patients) or the presence of idiotypic (Id) determinants (one patient) were used. With double immunofluorescence it was shown that the neoplastic blood B cells were heterogeneous in respect to maturation stage. In addition to B cells carrying membrane bound IgM and IgD (mIgM+/IgD+), both mIgM+/IgD- and cytoplasmic IgM+ blastoid cells could be detected in the blood of the patients. This heterogeneity was also reflected in the responses of the monoclonal B cells upon stimulation with mitogens and T cell factors. B blastoid cells and IgM secretion could be induced after in vitro culture in the presence of Staphylococcus aureus, Pokeweed mitogen or a combination of both mitogens. It was shown that also T cell factors were effective in inducing monoclonal B cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082547      PMCID: PMC1577336     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen.

Authors:  M Peters; A S Fauci
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

Review 2.  B cell growth and differentiation factors and mechanism of B cell activation.

Authors:  T Kishimoto; K Yoshizaki; M Kimoto; M Okada; T Kuritani; H Kikutani; K Shimizu; T Nakagawa; N Nakagawa; Y Miki
Journal:  Immunol Rev       Date:  1984-04       Impact factor: 12.988

3.  Interaction of staphylococcal protein A with membrane components of IgM- and/or IgD-bearing lymphocytes from human tonsil.

Authors:  S Romagnani; M G Giudizi; F Almerigogna; M Ricci
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

4.  Characterization of the monoclonal blood and bone marrow B lymphocytes in Waldenström's macroglobulinaemia.

Authors:  D Pettersson; H Mellstedt; G Holm
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

5.  IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.

Authors:  O Saiki; P Ralph
Journal:  Eur J Immunol       Date:  1982-06       Impact factor: 5.532

6.  Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical FC gamma and the alternative F(ab')2 epsilon protein A interactions.

Authors:  M Inganäs
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

7.  Immunoglobulins on the surface of lymphoid cells in Waldenström's macroglobulinemia.

Authors:  J L Preud'homme; M Seligmann
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

8.  Mouse red-cell rosettes in B-lymphoproliferative disorders.

Authors:  D Catovsky; M Cherchi; A Okos; U Hegde; D A Galton
Journal:  Br J Haematol       Date:  1976-06       Impact factor: 6.998

9.  Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.

Authors:  S Romagnani; M G Giudizi; R Biagiotti; F Almerigogna; E Maggi; G Del Prete; M Ricci
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

10.  Functional studies on B cells in human bone marrow: in vitro mitogen stimulation of normal and malignant B cells.

Authors:  L Hammarstróm; C I Smith; D Pettersson; H Mellstedt; G Holm
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.